SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-006396
Filing Date
2022-01-11
Accepted
2022-01-11 09:15:55
Documents
14
Period of Report
2022-01-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d139907d8k.htm   iXBRL 8-K 37531
2 EX-99.1 d139907dex991.htm EX-99.1 13954
6 GRAPHIC g139907g15r44.jpg GRAPHIC 2387
  Complete submission text file 0001193125-22-006396.txt   181029

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ttoo-20220111.xsd EX-101.SCH 2903
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttoo-20220111_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttoo-20220111_pre.xml EX-101.PRE 10960
8 EXTRACTED XBRL INSTANCE DOCUMENT d139907d8k_htm.xml XML 3231
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36571 | Film No.: 22522884
SIC: 3841 Surgical & Medical Instruments & Apparatus